Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 160

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome

Open access
Wang, Zhigang C., Birkbak, Nicolai Juul, Culhane, Aedín C., Drapkin, Ronny, Fatima, Aquila, Tian, Ruiyang, Schwede, Matthew, Alsop, Kathryn, Daniels, Kathryn E., Piao, Huiying, Liu, Joyce, Etemadmoghadam, Dariush, Miron, Alexander, Salvesen, Helga B., Mitchell, Gillian, DeFazio, Anna, Quackenbush, John, Berkowitz, Ross S., Iglehart, J. Dirk, Bowtell, David D.L., for the Australian Ovarian Cancer Study Group, Matulonis, Ursula A. · 2012 · Clinical Cancer Research

Abstract

Purpose: High-grade serous cancer (HGSC) is the most common cancer of the ovary and is characterized by chromosomal instability. Defects in homologous recombination repair (HRR) are associated with genomic instability in HGSC, and are exploited by therapy targeting DNA repair. Defective HRR causes uniparental deletions and loss of heterozygosity (LOH). Our purpose is to profile LOH in HGSC and correlate our findings to clinical outcome, and compare HGSC and high-grade breast cancers. Experimental Design: We examined LOH and copy number changes using single nucleotide polymorphism array data from three HGSC cohorts and compared results to a cohort of high-grade breast cancers. The LOH profiles in HGSC were matched to chemotherapy resistance and progression-free survival (PFS). Results: LOH-based clustering divided HGSC into two clusters. The major group displayed extensive LOH and was further divided into two subgroups. The second group contained remarkably less LOH. BRCA1 promoter methylation was associated with the major group. LOH clusters were reproducible when validated in two independent HGSC datasets. LOH burden in the major cluster of HGSC was similar to triple-negative, and distinct from other high-grade breast cancers. Our analysis revealed an LOH cluster with lower treatment resistance and a significant correlation between LOH burden and PFS. Conclusions: Separating HGSC by LOH-based clustering produces remarkably stable subgroups in three different cohorts. Patients in the various LOH clusters differed with respect to chemotherapy resistance, and the extent of LOH correlated with PFS. LOH burden may indicate vulnerability to treatment targeting DNA repair, such as PARP1 inhibitors. Clin Cancer Res; 18(20); 5806–15. ©2012 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-12-0857

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 160

Metadata

Authors
Wang, Z. C., Birkbak, N. J., Culhane, A. C., Drapkin, R., Fatima, A., Tian, R., Schwede, M., Alsop, K., Daniels, K. E., Piao, H., Liu, J., Etemadmoghadam, D., Miron, A., Salvesen, H. B., Mitchell, G., DeFazio, A., Quackenbush, J., Berkowitz, R. S., Iglehart, J. D., Bowtell, D. D. L., for the Australian Ovarian Cancer Study Group, & Matulonis, U. A.
Venue
Clinical Cancer Research
Published
2012-10-14
Volume
18
Issue
20
Pages
5806-5815
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2120801412
Cited by
160
References
4
FWCI
16.35
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-12-0857
The paper
Wang, Z. C., Birkbak, N. J., Culhane, A. C., Drapkin, R., Fatima, A., Tian, R., Schwede, M., Alsop, K., Daniels, K. E., Piao, H., Liu, J., Etemadmoghadam, D., Miron, A., Salvesen, H. B., Mitchell, G., DeFazio, A., Quackenbush, J., Berkowitz, R. S., Iglehart, J. D., . . . Matulonis, U. A. (2012). Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-12-0857

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.